Most likely like flexible injection – do not be fooled again – naturalnews.com

The CVXGA1 vaccine, developed by Cyanvac LLC, has led a new Covid-19 vaccine, developed by Cyanvac LLC, has led sharp criticism despite showing the promise in its clinical experience in the first stage. The vaccine, which can be sprayed and enters the body through the nasal corridor, aims to present An alternative to the injected MRNA Vaccines. However, scientists raise safety concerns, especially about the possibility of viral disposal and lack of strict clinical controls.

• Safety and design concerns about the Tofi nasal vaccine experienceThe first stage experience of the CVXGA1 Intranasal Mrna Covid-19 vaccine included only 72 participants, lacking an unpopular monitoring group, and used an open design, prompting several experts to criticize it as insufficient scientific to evaluate safety and effectiveness.
• The possibility of viral disposal raises alertThe researchers have warned that CVXGA1, which uses the direct Parainfluenza virus, may cause “constant shedding” through nasal secretions, and may display unlikely individuals – including weak population groups – to genetically modified viral particles.
• Conflict of interests and censorship Ltd.The entire experiment was funded by the Cyanvac vaccine developer, with many researchers who work before or financially linked to the company and other major pharmaceutical companies, raising questions about the independence of the results.
• Verily effects on genes -based vaccine connectionExperts expressed their concern that if it is considered successful, CVXGA1 can pave the way for the wide use of inhalation vaccines, despite the risk that is not resolved about exposure to pre -protein, long -term effects, and the lack of proper enlightened approval on self -platforms.

Experimental Covid vaccine trial that can be sprayed on safety concerns about getting rid of disposal, designing experiments, and transparency “

The results of the first stage were published in the first stage in Science progress It included 72 participants between the ages of 12 and 53, divided into high and low dose groups. According to the study, the high-dose set has seen less than Covid-19 cases of symptoms and lack of serious negative events or fever. The researchers concluded that the vaccine was well tolerated and produced an immune response.

Nevertheless, many scientists question the integrity and integrity of the experience. The lack of a small sample monitoring group weakens the reliability of conclusions. Dr. Kareena Asifido, ITIONATEATE from the Independent University of Mexico, said that the design of the study has failed to meet the standard standards for safety and effectiveness assessment. She said that the absence of a monitoring group “nullifies any explanation for safety and effectiveness.”

Another main anxiety is the possibility of viral shedding. Surveel journalist Sonia Elijah and other experts have warned that CVXGA1 could spread to non -fortified individuals through nose secretions. The vaccine uses a direct and protective virus-of the type Paeinfluenza virus Type 5-as it is directed to delivery, which raises warnings about its ability to repeat and get rid of environments in the real world. Dr. Karl Japonovsky of the health defense of children said this type of platform is risks to the weak population, such as infants and immunity, due to its own nature.

Experts also criticized the design of the open experience, which means that both participants and researchers know who received the vaccine. This can provide bias in assessing negative events or results. Moreover, the study monitored the side effects of only limited time, which may lack serious health issues that can appear later.

The lack of specific data for adolescents, and the assessments of unlimited DNA detection, and there is no test of infection for the shed materials undermining the accuracy of the scientific trial, according to Elijah. She emphasized that without testing whether the vaccine could spread to others, it is impossible to know its impact on complete public health.

Fears of conflict of interest have also emerged. Cyanvac has fully funded the experience, and many researchers concerned have financial relationships with Cyanvac or other vaccine manufacturers such as Pfizer, Moderna and Astrazneca. The Cincinnati Children’s Hospital, which hosted the experiment, also conducted the experiments of the Pfizer vaccine by adolescents, including a host that includes Madi de Jaray, a participant who was seriously injured. Critics argue that previous incidents raise questions about transparency and accountability.

With CVXGA1 move to the second stage experiences with plans to record 10,000 participants, scientists demand an increase in supervision, independent evaluation and a complete disclosure of risks. The future of spraying vaccines may be dependent on the extent of this next stage, safely and morally.

Reference Vaccines To your favorite independent websites to get updates about experimental genetic therapy injection, pollen and even “sprays” that lead to premature death, infertility, turbo cancer SYNDROME.

Sources of this article include:

PandeMic.News

NaturalNews.com

Childrenshealthdefense.org